Table 2.
Univariate analysis of outcome
| Parameter | N | EFS 2-yr % | P value | OS 2-yr % | P value |
|---|---|---|---|---|---|
| Age | |||||
| ≤ 40 years | 22 | 71 | 0.20 | 68 | 0.7 |
| > 40 years | 19 | 90 | 76 | ||
| Sex | |||||
| Male | 22 | 71 | 0.1 | 72 | 0.29 |
| Female | 19 | 90 | 83 | ||
| HIV status | |||||
| Positive | 12 | 67 | 0.1 | 67 | 0.21 |
| Negative | 29 | 85 | 74 | ||
| Stage | |||||
| 1,2 | 18 | 89 | 0.2 | 82 | 0.29 |
| 3,4 | 23 | 78 | 73 | ||
| Subtype of NHL | |||||
| BL | 32 | 80 | 0.138 | 77 | 0.124 |
| PMBCL | 5 | 100 | 100 | ||
| DLBCL | 4 | 50 | 50 | ||
| Risk group | |||||
| aaIPI code 0,1 | 17 | 85 | 0.2 | 72 | 0.32 |
| aaIPI score 2,3 | 24 | 75 | 70 | ||
EFS event-free survival, BL Burkitt’s lymphoma, PMBCL primary mediastinal B cell lymphoma, DLBCL diffuse large B cell lymphoma, aaIPI age adjusted International prognostic index